Repare Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
16 Nov 23 | BuyUS$6,249,889 | BVF Partners L.P. | Company | 1,227,301 | US$5.38 | |
02 Nov 23 | BuyUS$2,821,352 | BVF Partners L.P. | Company | 783,709 | US$3.60 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 422,007 | 0.994% |
General Public | 4,642,800 | 10.9% |
Hedge Funds | 10,333,600 | 24.3% |
VC/PE Firms | 11,584,280 | 27.3% |
Institutions | 15,462,846 | 36.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
10,333,600 | US$36.5m | 0% | 0.88% | |||
3,372,499 | US$11.9m | 8.01% | 4.24% | |||
3,322,488 | US$11.7m | 0% | 0.16% | |||
3,122,499 | US$11.0m | 0% | 39.39% | |||
2,646,657 | US$9.3m | 0% | 3.19% | |||
2,630,364 | US$9.3m | -2.72% | 0.08% | |||
2,242,636 | US$7.9m | 0% | 4.18% | |||
1,942,555 | US$6.9m | -3.66% | 0.31% | |||
1,639,849 | US$5.8m | 0% | 0.86% | |||
956,932 | US$3.4m | 51.1% | 3.21% | |||
904,261 | US$3.2m | -66.3% | 0.08% | |||
674,089 | US$2.4m | -9.82% | 0.13% | |||
458,700 | US$1.6m | 30.7% | no data | |||
417,929 | US$1.5m | 212% | no data | |||
299,654 | US$1.1m | 137% | 0.07% | |||
295,753 | US$1.0m | 2.86% | no data | |||
277,168 | US$978.4k | -10.1% | no data | |||
249,475 | US$880.6k | 47.7% | no data | |||
199,776 | US$705.2k | -0.15% | no data | |||
149,574 | US$528.0k | 24.5% | no data | |||
142,974 | US$504.7k | 428% | no data | |||
141,803 | US$500.6k | 131% | no data | |||
140,361 | US$495.5k | 111% | no data | |||
117,869 | US$416.1k | -0.26% | no data | |||
110,935 | US$391.6k | 5.39% | no data |